Hisamitsu Pharmaceutical Co Inc - ESG Rating & Company Profile powered by AI
The webpage is a free Sustainability analysis for Hisamitsu Pharmaceutical Co Inc. Check the bottom of the webpage for potential risks for Hisamitsu Pharmaceutical Co Inc based on industry, location and marketcap. The analysis of Hisamitsu Pharmaceutical Co Inc uses data from across the web and also from available disclosures by Hisamitsu Pharmaceutical Co Inc.
Hisamitsu Pharmaceutical Co Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 8.0 and governance score of 8.0.
8.0
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 36 | Repligen Corp | 8.1 | High |
| 36 | Zealand Pharma A/S | 8.1 | High |
| 55 | Hisamitsu Pharmaceutical Co Inc | 8.0 | High |
| 55 | Abbott India Ltd | 8.0 | High |
| 55 | Amrutanjan Health Care Ltd | 8.0 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Hisamitsu Pharmaceutical Co Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Hisamitsu Pharmaceutical Co Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Hisamitsu Pharmaceutical Co Inc report the average age of the workforce?
Sign up for free to unlockDoes Hisamitsu Pharmaceutical Co Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Hisamitsu Pharmaceutical Co Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Hisamitsu Pharmaceutical Co Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Hisamitsu Pharmaceutical Co Inc offer flexible work?
Sign up for free to unlockDoes Hisamitsu Pharmaceutical Co Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Hisamitsu Pharmaceutical Co Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Hisamitsu Pharmaceutical Co Inc conduct supply chain audits?
Sign up for free to unlockDoes Hisamitsu Pharmaceutical Co Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Hisamitsu Pharmaceutical Co Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Hisamitsu Pharmaceutical Co Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Hisamitsu Pharmaceutical Co Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Hisamitsu Pharmaceutical Co Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Hisamitsu Pharmaceutical Co Inc disclose water use targets?
Sign up for free to unlockDoes Hisamitsu Pharmaceutical Co Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Hisamitsu Pharmaceutical Co Inc have a product recall in the last two years?
Sign up for free to unlockDoes Hisamitsu Pharmaceutical Co Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Hisamitsu Pharmaceutical Co Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Hisamitsu Pharmaceutical Co Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Hisamitsu Pharmaceutical Co Inc disclose parental leave metrics?
Sign up for free to unlockDoes Hisamitsu Pharmaceutical Co Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Hisamitsu Pharmaceutical Co Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Hisamitsu Pharmaceutical Co Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Hisamitsu Pharmaceutical Co Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Hisamitsu Pharmaceutical Co Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Hisamitsu Pharmaceutical Co Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Hisamitsu Pharmaceutical Co Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Hisamitsu Pharmaceutical Co Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Hisamitsu Pharmaceutical Co Inc disclose its waste policy?
Sign up for free to unlockDoes Hisamitsu Pharmaceutical Co Inc report according to TCFD requirements?
Sign up for free to unlockDoes Hisamitsu Pharmaceutical Co Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Hisamitsu Pharmaceutical Co Inc disclose energy use targets?
Sign up for free to unlockDoes Hisamitsu Pharmaceutical Co Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Hisamitsu Pharmaceutical Co Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Hisamitsu Pharmaceutical Co Inc
These potential risks are based on the size, segment and geographies of the company.
Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals, quasi-drugs, and medical devices in Japan. The company provides external pain relieving drugs under the SALONPAS, NOBINOBI, SALONSIP, AIR, SALONPAS, and FEITAS; and BUTENALOCK, a remedy for athlete's foot, as well as ALLEGRA FX, a sinus medication for allergies. It also manufactures and sells quasi-drugs and cosmetics; MOHRUS TAPE and MOHRUS PAP XR, transdermal analgesic anti-inflammatory drug; patches for female hormone, asthma treatment, and treatment for overactive bladders. In addition, the company manufactures and sells drugs under MOHRUS TAPE, MOHRUS PAP XR, FENTOS Tapes, NEOXY Tapes, Abstral, ALLESAGA Tapes, HARUROPI Tapes, and MENOAID Combipatch. Further, it provides HFT-290, a transdermal patch for cancer pain. The company sells its products in the United States and Asia. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan.